Suchen Sie nach Informationen zu Hauptsitz Von Aegera Therapeutics Inc? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
https://www.crunchbase.com/organization/aegera-therapeutics-inc
Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies
https://opencorporates.com/companies/ca/3775739
AEGERA THERAPEUTICS INC. Company Number 3775739 Status Inactive Amalgamated Incorporation Date 19 May 2000 (almost 22 years ago) Dissolution Date 25 May 2011 Company Type Non-distributing corporation with more than 50 shareholders Jurisdiction Canada Business Number 894407394RC0002 Registered Address.
https://opencorporates.com/companies/ca/7846193
AEGERA THERAPEUTICS INC. Company Number 7846193 Status Dissolved By The Corporation (S. 210) Incorporation Date 25 May 2011 (over 10 years ago) Dissolution Date 23 July 2018 Company Type ... AEGERA THÉRAPEUTIQUE INC. (alternative legal name, 2011-05-25 - ) Inactive Directors / Officers.
https://www.linkedin.com/company/aegera-therapeutics-inc.
Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs.
https://www.bloomberg.com/profile/company/1046426Z:CN
Company profile page for Aegera Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information
https://pitchbook.com/profiles/company/52235-11
Description. Developer of targeted therapeutics to address major unmet medical needs. The company has various programs investigating on various areas, such as relapsed or refractory chronic lymphocytic and acute myeloid leukemia; small lymphocytic and follicular lymphoma; non small cell lung cancer and haematological cancer; pancreatic cancer; solid tumor patients for …
https://www.slintel.com/company/aegera-therapeutics-inc/5c3b0030d55ae49f1b7620ce
Find useful insights on Aegera Therapeutics Inc’s company details, tech stack, news alerts, competitors and more. Use Slintel to connect with top decision-makers at Aegera Therapeutics Inc.
https://hbw.pharmaintelligence.informa.com/SC090284/Aegera-Therapeutics-Inc
Aegera Therapeutics Inc. was formed in May 2000 through the merger of Apoptogen Inc. and Exogen Neurosciences Inc. Aegera will build on the neural signal transduction and apoptosis platforms of its founding companies with a goal of discovering and developing therapeutics for neurodegenerative diseases, peripheral neuropathies and cancer.
https://www.bionity.com/en/news/66954/aegera-therapeutics-acquires-clinical-stage-oncology-company-and-closes-concurrent-financing.html
Aegera Therapeutics announced the acquisition of LymphoSign Inc. and its clinical oncology program LS104, a small molecule tyrosine kinase inhibitor …
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Hauptsitz Von Aegera Therapeutics Inc gefunden haben.
